CMPX

Compass Therapeutics Inc.

Price

$0.84

return (12m)

-80.27%

p/e

-2.25

p/bv

0.99

DIVIDEND YIELD

0.00%

CMPX price

Compass Therapeutics Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment CMPX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-53.95%

3 months

-59.10%

1 year

-80.27%

2 years

-54.70%

5 years

-74.38%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CMPX

Valuation

P/E

-2.25

Sector 7.79

Industry 7.79

P/BV

0.99

Sector 1.68

Industry 1.68

P/Revenue (PSR)

Sector 1.67

Industry 1.67

EV/EBITDA

0.56

Sector -30,054.56

Industry -30,054.56

EV/EBIT

0.55

Sector -93,499.28

Industry -93,499.28

P/EBITDA

-2.07

Sector -11.35

Industry -11.35

P/EBIT

-2.03

Sector -10.01

Industry -10.01

P/Total Assets

0.87

Sector 0.78

Industry 0.78

P/Net Current Assets

1.05

Sector -1.81

Industry -1.81

P/Working Capital

1.00

Sector -5,061.28

Industry -5,061.28

EPS

-0.39

Sector 0.71

Industry 0.71

BVPS

0.89

Sector 9.77

Industry 9.77

Efficiency

Gross Margin

0.00%

Sector 35.83%

Industry 35.83%

EBITDA Margin

Sector -192.23%

Industry -192.23%

EBIT Margin

0.00%

Sector 4.35%

Industry 4.35%

Net Profit Margins

0.00%

Sector 2.49%

Industry 2.49%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-44.23%

Sector 2.41%

Industry 2.41%

ROA

-38.62%

Sector -0.72%

Industry -0.72%

ROIC

-858.86%

Sector -109.90%

Industry -109.90%

Dividends

Dividend yield

0.00%

Sector 0.52%

Industry 0.52%

Payout

Sector 9.98%

Industry 9.98%

Debt

Current Ratio

11.22

Sector 1.47

Industry 1.47

Net Debt / EBITDA

6.76

Sector -19.97

Industry -19.97

Net Debt / EBIT

6.67

Sector -161,412,481.11

Industry -161,412,481.11

Net Debt / Equity

-1.08

Sector -0.88

Industry -0.88

Gross Debt / Equity

0.00

Sector -0.52

Industry -0.52

Equity/Assets

0.87

Sector 0.43

Industry 0.43

Liabilities/Assets

0.13

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-2.22%

Sector -

Industry -

Fundamentals CMPX

DRAG THE FRAME TO SEE MORE DATA

CMPX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Compass Therapeutics Inc.

Compass Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

39

Employees

Compass Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $165.00 million, with shareholders equity totaling $166.05 million.

The company employs approximately 39 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Compass Therapeutics Inc. reported $- in revenue, generating net income of $-73.45 million.

Key financial metrics include a P/E ratio of -2.25, a price-to-book (P/B) ratio of 0.99, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CMPX.

Market cap

$165.00 million

Net worth

$166.05 million

$166,049,000.00

Assets

$190.17 million

$190,173,000.00

Total Shares Outstanding

186.80 million

186,798,000

Average Daily Trading Volume

$4.68 million

$4,684,394.98

Sector

Others

Industry

Others

CMPX

CMPX revenue and profits

Financial Results CMPX

DRAG THE FRAME TO SEE MORE DATA

CMPX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$401.76 15,66% (12M)

P/E

25.57

2.26%

ROE

13.51%

P/BV

3.45

SHEL - Shell PLC ADR

$105.12 50,21% (12M)

P/E

11.38

2.86%

ROE

14.29%

P/BV

1.63

STLA - Stellantis NV

$4.30 --59,33% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$337.52 4,74% (12M)

P/E

25.10

0.70%

ROE

81.03%

P/BV

20.34

ALIZY - Allianz SE ADR

$47.63 --14,48% (12M)

P/E

13.37

2.80%

ROE

17.89%

P/BV

2.39

TTE - TotalEnergies SE ADR

$90.10 55,78% (12M)

P/E

6.98

4.69%

ROE

21.42%

P/BV

1.50

NSRGY - Nestle SA ADR

$99.70 --3,23% (12M)

P/E

11.97

4.02%

ROE

58.05%

P/BV

6.95

ELV - Elevance Health Inc

$426.91 24,83% (12M)

P/E

21.14

1.60%

ROE

9.84%

P/BV

2.08